Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
School-leaving booster immunogenicity study of Td5ap versus Td1aP in adolescents
2008-008195-13Phase 4Completed
- Sponsor
- Swedish Institute for Infectious Disease Control
- Start
- Dec 2008
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of diphtheria, tetanus, and acellular pertussis vaccine and tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine in diphtheria, Tetanus and pertussis (2 arms), sponsored by Swedish Institute for Infectious Disease Control. Primary endpoints: Immunogenicity to diphtheria toxin, Immunogenicity to tetanus toxoid and 4 more. Started Dec 2008; status: completed.
02
Drugs
diphtheria, tetanus, and acellular pertussis vaccinetetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2008-008195-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008195-13.